Outcomes of Complicated CL in Ethiopia Treated With Miltefosine
NCT04004754
·
clinicaltrials.gov ↗
COMPLETED
Status
94
Enrollment
OTHER
Sponsor class
Conditions
Cutaneous Leishmaniases
Interventions
DRUG:
Miltefosine (administration is not part of study procedures)
Sponsor
Institute of Tropical Medicine, Belgium
Collaborators
[object Object]
[object Object]